Biocept, Inc.
BIOCQ
$0.0001
$0.000.00%
Rating
Reward
--
--
Risk
--
--
Rating Factors
Growth Index
--
Efficiency Index
--
Solvency Index
--
Total Return Index
--
Volatility Index
--
Dividend Index
--
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, August 14, 2023
Period Date
Friday, June 30, 2023
Next Filing
(est)
Price History
Beta
7-Day Total Return
30-Day Total Return
--
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
858 320 8200
Address
9955 Mesa Rim Road
San Diego, CA 92121
San Diego, CA 92121
Country
Year Founded
Business Description
Sector
Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary clinical diagnostic laboratory assays designed to identify rare tumor cells and cell-free tumor...
more
